GKSL
GKSL · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for GKSL quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Reply to Clarification- Financial results
10 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
10 Jul 2026
Acquisition
10 Jul 2026
Appointment
10 Jul 2026
Shareholders meeting
06 Jul 2026
Trading Window
27 Jun 2026
Clarification - Financial Results
25 Jun 2026
Shareholders meeting
04 Jun 2026
Copy of Newspaper Publication
04 Jun 2026
Copy of Newspaper Publication
29 May 2026
Change in Management
29 May 2026
Change in Management
29 May 2026
Outcome of Board Meeting
29 May 2026
Disclosure under SEBI Takeover Regulations
27 May 2026
Monitoring Agency Report
15 May 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
No corporate actions available from NSE right now.
Board Meetings
28 May 2026
To consider and approve the audited financial results for the quarter and year ended March 31, 2026 and other matters
28 May 2026
GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Other business.
14 Feb 2026
Gujarat Kidney and Super Speciality Limited has informed the Exchange about Board Meeting to be held on 14-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.
14 Feb 2026
The Company has informed the Exchange that a Board meeting to be held on February 13, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 14, 2026, To consider and approve the financial results for the period ended December 31, 2025 and other business matters
13 Feb 2026
Gujarat Kidney and Super Speciality Limited has informed the Exchange about Board Meeting to be held on 13-Feb-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.
13 Feb 2026
To consider and approve the financial results for the period ended December 31, 2025 and other business matters